The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.

<h4>Background</h4>The enhanced liver fibrosis test (ELF) has been shown to accurately predict significant liver fibrosis in several liver diseases.<h4>Aims</h4>To perform a meta-analysis to assess the performance of the ELF test for the assessment of liver fibrosis.<h4>...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qingsong Xie, Xiaohu Zhou, Pengfei Huang, Jianfeng Wei, Weilin Wang, Shusen Zheng
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a9c9e5c49563410caa924ddbb4c6a162
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a9c9e5c49563410caa924ddbb4c6a162
record_format dspace
spelling oai:doaj.org-article:a9c9e5c49563410caa924ddbb4c6a1622021-11-18T08:23:10ZThe performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.1932-620310.1371/journal.pone.0092772https://doaj.org/article/a9c9e5c49563410caa924ddbb4c6a1622014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24736610/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The enhanced liver fibrosis test (ELF) has been shown to accurately predict significant liver fibrosis in several liver diseases.<h4>Aims</h4>To perform a meta-analysis to assess the performance of the ELF test for the assessment of liver fibrosis.<h4>Study</h4>Electronic and manual searches were performed to identify studies of the ELF test. After methodological quality assessment and data extraction, pooled estimates of the sensitivity, specificity, area under the receiver operating characteristic curve (AUROC), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and summary receiver operating characteristics (sROC) were assessed systematically. The extent of heterogeneity and reasons for it were assessed.<h4>Results</h4>Nine studies were identified for analysis. The pooled sensitivity, specificity, positive LR, negative LR, and DOR values of ELF test, for assessment of significant liver fibrosis, were 83% (95% CI=0.80-0.86), 73% (95% CI=0.69-0.77), 4.00 (95% CI=2.50-6.39), 0.24 (95% CI=0.17-0.34), and 16.10 (95% CI=8.27-31.34), respectively; and, for evaluation of severe liver fibrosis, were 78% (95% CI=0.74-0.81), 76% (95% CI=0.73-0.78), 4.39 (95% CI=2.76-6.97), 0.27 (95% CI=0.16-0.46), and 16.01 (95% CI: 7.15-35.82), respectively; and, for estimation of cirrhosis, were 80% (95% CI=0.75-0.85), 71% (95% CI=0.68-0.74), 3.13 (95% CI=2.01-4.87), 0.29 (95% CI=0.19-0.44), and 14.09 (95% CI: 5.43-36.59), respectively.<h4>Conclusions</h4>The ELF test shows good performance and considerable diagnostic value for the prediction of histological fibrosis stage.Qingsong XieXiaohu ZhouPengfei HuangJianfeng WeiWeilin WangShusen ZhengPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 4, p e92772 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Qingsong Xie
Xiaohu Zhou
Pengfei Huang
Jianfeng Wei
Weilin Wang
Shusen Zheng
The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.
description <h4>Background</h4>The enhanced liver fibrosis test (ELF) has been shown to accurately predict significant liver fibrosis in several liver diseases.<h4>Aims</h4>To perform a meta-analysis to assess the performance of the ELF test for the assessment of liver fibrosis.<h4>Study</h4>Electronic and manual searches were performed to identify studies of the ELF test. After methodological quality assessment and data extraction, pooled estimates of the sensitivity, specificity, area under the receiver operating characteristic curve (AUROC), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and summary receiver operating characteristics (sROC) were assessed systematically. The extent of heterogeneity and reasons for it were assessed.<h4>Results</h4>Nine studies were identified for analysis. The pooled sensitivity, specificity, positive LR, negative LR, and DOR values of ELF test, for assessment of significant liver fibrosis, were 83% (95% CI=0.80-0.86), 73% (95% CI=0.69-0.77), 4.00 (95% CI=2.50-6.39), 0.24 (95% CI=0.17-0.34), and 16.10 (95% CI=8.27-31.34), respectively; and, for evaluation of severe liver fibrosis, were 78% (95% CI=0.74-0.81), 76% (95% CI=0.73-0.78), 4.39 (95% CI=2.76-6.97), 0.27 (95% CI=0.16-0.46), and 16.01 (95% CI: 7.15-35.82), respectively; and, for estimation of cirrhosis, were 80% (95% CI=0.75-0.85), 71% (95% CI=0.68-0.74), 3.13 (95% CI=2.01-4.87), 0.29 (95% CI=0.19-0.44), and 14.09 (95% CI: 5.43-36.59), respectively.<h4>Conclusions</h4>The ELF test shows good performance and considerable diagnostic value for the prediction of histological fibrosis stage.
format article
author Qingsong Xie
Xiaohu Zhou
Pengfei Huang
Jianfeng Wei
Weilin Wang
Shusen Zheng
author_facet Qingsong Xie
Xiaohu Zhou
Pengfei Huang
Jianfeng Wei
Weilin Wang
Shusen Zheng
author_sort Qingsong Xie
title The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.
title_short The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.
title_full The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.
title_fullStr The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.
title_full_unstemmed The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.
title_sort performance of enhanced liver fibrosis (elf) test for the staging of liver fibrosis: a meta-analysis.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/a9c9e5c49563410caa924ddbb4c6a162
work_keys_str_mv AT qingsongxie theperformanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT xiaohuzhou theperformanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT pengfeihuang theperformanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT jianfengwei theperformanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT weilinwang theperformanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT shusenzheng theperformanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT qingsongxie performanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT xiaohuzhou performanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT pengfeihuang performanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT jianfengwei performanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT weilinwang performanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
AT shusenzheng performanceofenhancedliverfibrosiselftestforthestagingofliverfibrosisametaanalysis
_version_ 1718421879926030336